Stock screenerAll disclosures →
EDGAR →
ANAB
Conviction 27HealthcareScan · Mon, Aug 10, 2026ANAB$55.45-2.05%
ResistanceSupportVol 14Vol MA14 538.44K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price55.45
Change-2.05%
Gap-0.11%
Rel volume0.75×
Avg volume691.35K
Avg $ vol37.71M
SMA 2054.65
SMA 5057.28
SMA 20053.34
Price vs 50-3.20%
Price vs 200+3.95%
MA stackmixed
50/200 cross—
Supertrenddown · 63.57
RSI (14)48
MACD hist0.34
MACD crossbull · 3d
Stoch %K / %D60 / 68
ADX (14)12
+DI / −DI24 / 16
RSI divergence—
MACD divergence—
ATR %+6.11%
ADR %6.54%
52w high70.22
52w low19.40
From 52w high-21.03%
Above 52w low+185.82%
New 52w highNo
SqueezeOff
Bollinger width17.96%
%B0.58
Donchian pos27.08%
Donchian high70.91
Donchian low49.71
AVWAP (52w high)59.61
vs AVWAP high-6.97%
AVWAP (52w low)50.61
vs AVWAP low+9.57%
OBV trendDown
Chaikin MF (20)-0.12
Today vs 20d0.75×
Avg vol (14d)538.43K
Avg vol (20d)691.35K
Avg $ vol (20d)37.71M
Market cap1.61B
RS 3m (vs SPY)-21.15%
RS 6m (vs SPY)+4.07%
RS line new highNo
Trend template4/8
Technical rank45.3
1 week+3.34%
1 month-16.48%
3 months-20.02%
6 months+11.50%
1 year+172.21%
YTD+23.36%
P/E-121.95
P/B126.59
P/S6.88
P/FCF82.29
EPS-0.4600
Div yield—
ROE-103.80%
ROA-4.01%
Debt/Eq—
Current7.58
EV/EBITDA28.17
Gross margin—
Net margin-5.64%
Rev growth157.01%
EPS growth90.89%
Price target80.67
Target upside45.48%
Analyst ratingBuy
Institutional102.57%
Ent. value1.37B
Revenue25.56M
Net income-52.88M
Gross profit—
Free cash flow19.61M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out29.1M
Employees104
ListedThu, Jan 26, 2017
Free float17.05M
Float %61.6%
Short interest5M
Days to cover5.9d
Short volume76.8%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.84 vs −$0.32
Last surprise-475.0% miss
Setup gradeD
Conviction27 / 100
Pattern quality—
Tech rank45.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance70.09
Support50.11
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ANAB
No recent disclosed trades by Congress in ANAB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ANAB · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Faga Daniel President, CEO · Performance Stock Units · 2026-03-12 | Grant | 53.33K | — | 2026-03-12 | 2026-08-07 |
Lizzul Paul F. Chief Medical Officer · Performance Stock Units · 2026-03-12 | Grant | 16.67K | — | 2026-03-12 | 2026-08-07 |
RENTON HOLLINGS Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
RENTON HOLLINGS Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Orwin John A Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Orwin John A Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Schmid John P. Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Schmid John P. Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Murphy Christopher M. Chief Financial Officer · Restricted Stock Units · 2026-05-11 | Grant | 25.77K | $0 | 2026-05-11 | 2026-05-13 |
Hughes Owen Director · Restricted Stock Units · 2026-05-11 | Grant | 11.25K | $0 | 2026-05-11 | 2026-05-13 |
SEC filings
EDGAR filings in ANAB · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.